DNA microarray analysis reveals a role for lysophosphatidic acid in the regulation of anti-inflammatory genes in MC3T3-E1 cells

Bone

Volumn 41, Issue 5, 2007, Pages 833-841

  Waters, Katrina M ^a   Tan, Ruimin ^a   Genetos, Damian C ^b   Verma, Seema ^a   Yellowley, Clare E ^c   Karin, Norman J ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA microarray; Gene expression; Inflammation; Lysophosphatidic acid; Osteoblast

Indexed keywords

CALCIUM; DNA; G PROTEIN COUPLED RECEPTOR; GENE PRODUCT; KI 16425; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; PERTUSSIS TOXIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE STRESS; CELL MOTILITY; CELL PROLIFERATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; DNA MICROARRAY; DRUG INHIBITION; FRACTURE HEALING; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; OSTEOBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEAR STRESS;

EID: 35348867439     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.06.029     Document Type: Article

References (61)

1. Goetzl E.J. Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids. Prostaglandins 64 (2001) 11-20
2. Eichholtz T., Jalink K., Fahrenfort I., and Moolenaar W.H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 291 Pt. 3 (1993) 677-680
3. Sano T., Baker D., Virag T., Wada A., Yatomi Y., Kobayashi T., et al. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J Biol Chem 277 (2002) 21197-21206
4. Lee H., Goetzl E.J., and An S. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol 278 (2000) C612-C618
5. Themistocleous G.S., Kontou S.E., Lembessis P., Katopodis H.A., Kaseta M.A., Themistocleous M.S., et al. Skeletal growth factor involvement in the regulation of fracture healing process. In Vivo 17 (2003) 489-503
6. Caverzasio J., Palmer G., Suzuki A., and Bonjour J.P. Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells. J Bone Miner Res 15 (2000) 1697-1706
7. Dziak R., Yang B.M., Leung B.W., Li S., Marzec N., Margarone J., et al. Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells. Prostaglandins Leukot Essent Fat Acids 68 (2003) 239-249
8. Grey A., Banovic T., Naot D., Hill B., Callon K., Reid I., et al. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve Gi proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases. Endocrinology 142 (2001) 1098-1106
9. Grey A., Chen Q., Callon K., Xu X., Reid I.R., and Cornish J. The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving Gi proteins and phosphatidylinositol-3 kinase. Endocrinology 143 (2002) 4755-4763
10. Masiello L.M., Fotos J.S., Galileo D.S., and Karin N.J. Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells. Bone 39 (2006) 72-82
11. Karagiosis S.A., and Karin N.J. Lysophosphatidic acid induces osteocyte dendrite outgrowth. Biochem Biophys Res Commun 57 (2007) 194-199
12. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res (1998) S7-S21
13. Liu R., Farach-Carson M.C., and Karin N.J. Effects of sphingosine derivatives on MC3T3-E1 pre-osteoblasts: psychosine elicits release of calcium from intracellular stores. Biochem Biophys Res Commun 214 (1995) 676-684
14. 2+. Biochem Biophys Res Commun 273 (2000) 95-100
15. 2+ signaling in MC3T3-E1 osteoblastic cells. J Bone Miner Res 16 (2001) 2035-2042
16. Gräler M.H., and Goetzl E.J. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta 1582 (2002) 168-174
17. Marriott I. Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression. Immunol Res 30 (2004) 291-308
18. Ryu J., Kim H.J., Chang E.J., Huang H., Banno Y., and Kim H.H. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J 25 (2006) 5840-5851
19. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003) 249-264
20. Dudoit S., van der Laan M.J., and Pollard K.S. Multiple testing: Part I. Single-step procedures for control of general type I error rates. Stat Appl Genet Mol Biol 3 (2004) [Article 13]
21. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5 (2004) R80
22. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30 (2002) e36
23. Haut Donahue T.L., Genetos D.C., Jacobs C.R., Donahue H.J., and Yellowley C.E. Annexin V disruption impairs mechanically induced calcium signaling in osteoblastic cells. Bone 35 (2004) 656-663
24. Eferl R., Hoebertz A., Schilling A.F., Rath M., Karreth F., Kenner L., et al. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J 23 (2004) 2789-2799
25. Iqbal J., and Zaidi M. Molecular regulation of mechanotransduction. Biochem Biophys Res Commun 328 (2005) 751-755
26. Street J., Bao M., de Guzman L., Bunting S., Peale Jr. F.V., Ferrara N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 99 (2002) 9656-9661
27. Krishnan V., Bryant H.U., and Macdougald O.A. Regulation of bone mass by Wnt signaling. J Clin Invest 116 (2006) 1202-1209
28. Cornish J., Naot D., and Reid I.R. Adrenomedullin-a regulator of bone formation. Regul Pept 112 (2003) 79-86
29. Hankenson K.D., Ausk B.J., Bain S.D., Bornstein P., Gross T.S., and Srinivasan S. Mice lacking thrombospondin 2 show an atypical pattern of endocortical and periosteal bone formation in response to mechanical loading. Bone 38 (2006) 310-316
30. Ueno A., Miwa Y., Miyoshi K., Horiguchi T., Inoue H., Ruspita I., et al. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization. J Cell Physiol 209 (2006) 322-332
31. Strand V., and Kavanaugh A.F. The role of interleukin-1 in bone resorption in rheumatoid arthritis. Rheumatology (Oxford) 43 Suppl. 3 (2004) iii10-iii16
32. Ishii I., Fukushima N., Ye X., and Chun J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem 73 (2004) 321-354
33. q-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem 281 (2006) 23589-23597
34. Ohta H., Sato K., Murata N., Damirin A., Malchinkhuu E., Kon J., et al. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol 64 (2003) 994-1005
35. Ohata H., Tanaka K.I., Maeyama N., Ikeuchi T., Kamada A., Yamamoto M., et al. Physiological and pharmacological role of lysophosphatidic acid as modulator in mechanotransduction. Jpn J Pharmacol 87 (2001) 171-176
36. Weinberg E.O., Shimpo M., De Keulenaer G.W., MacGillivray C., Tominaga S., Solomon S.D., et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106 (2002) 2961-2966
37. Mark H., Penington A., Nannmark U., Morrison W., and Messina A. Microvascular invasion during endochondral ossification in experimental fractures in rats. Bone 35 (2004) 535-542
38. Shin H.H., Lee E.A., Kim S.J., Kwon B.S., and Choi H.S. A signal through 4-1BB ligand inhibits receptor for activation of nuclear factor-kB ligand (RANKL)-induced osteoclastogenesis by increasing interferon (IFN)-beta production. FEBS Lett 580 (2006) 1601-1606
39. Hankenson K.D., Bain S.D., Kyriakides T.R., Smith E.A., Goldstein S.A., and Bornstein P. Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J Bone Miner Res 15 (2000) 851-862
40. Nanki T., Shimaoka T., Hayashida K., Taniguchi K., Yonehara S., and Miyasaka N. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 52 (2005) 3004-3014
41. Trajkovic V., Sweet M.J., and Xu D. T1/ST2-an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev 15 (2004) 87-95
42. Sudo H., Kodama H.A., Amagai Y., Yamamoto S., and Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96 (1983) 191-198
43. Klemenz R., Hoffmann S., and Werenskiold A.K. Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc Natl Acad Sci U S A 86 (1989) 5708-5712
44. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 258 (1989) 301-304
45. Werenskiold A.K., Hoffmann S., and Klemenz R. Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. Mol Cell Biol 9 (1989) 5207-5214
46. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., and McClanahan T.K. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23 (2005) 479-490
47. Leung B.P., Xu D., Culshaw S., McInnes I.B., and Liew F.Y. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol 173 (2004) 145-150
48. Xu D., Chan W.L., Leung B.P., Huang F., Wheeler R., Piedrafita D., et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187 (1998) 787-794
49. Sweet M.J., Leung B.P., Kang D., Sogaard M., Schulz K., Trajkovic V., et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 166 (2001) 6633-6639
50. Kozawa O., Niwa M., Matsuno H., Tokuda H., Miwa M., Ito H., et al. Sphingosine 1-phosphate induces heat shock protein 27 via p38 mitogen-activated protein kinase activation in osteoblasts. J Bone Miner Res 14 (1999) 1761-1767
51. Ehrnsperger M., Graber S., Gaestel M., and Buchner J. Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J 16 (1997) 221-229
52. Garrido C., Gurbuxani S., Ravagnan L., and Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 286 (2001) 433-442
53. Lavoie J.N., Lambert H., Hickey E., Weber L.A., and Landry J. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 15 (1995) 505-516
54. Piotrowicz R.S., Hickey E., and Levin E.G. Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration. FASEB J 12 (1998) 1481-1490
55. De A.K., Kodys K.M., Yeh B.S., and Miller-Graziano C. Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an antiinflammatory stimulus. J Immunol 165 (2000) 3951-3958
56. Sumioka I., Matsura T., Kai M., and Yamada K. Potential roles of hepatic heat shock protein 25 and 70i in protection of mice against acetaminophen-induced liver injury. Life Sci 74 (2004) 2551-2561
57. Wischmeyer P.E., Kahana M., Wolfson R., Ren H., Musch M.M., and Chang E.B. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 90 (2001) 2403-2410
58. 2+-dependent transcription. Curr Opin Neurobiol 11 (2001) 312-319
59. Gächter T., Werenskiold A.K., and Klemenz R. Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J Biol Chem 271 (1996) 124-129
60. 2+ regulates fluid shear-induced cytoskeletal reorganization and gene expression in osteoblasts. Am J Physiol Cell Physiol 278 (2000) C989-C9897
61. Liedert A., Kaspar D., Blakytny R., Claes L., and Ignatius A. Signal transduction pathways involved in mechanotransduction in bone cells. Biochem Biophys Res Commun 349 (2006) 1-5